1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CCR
  4. CCR Inhibitors

CCR Inhibitors

CCR1

CCR2

CCR3

CCR4

CCR5

CCR6

CCR7

CCR8

CCR9

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

CCR Inhibitors, Agonists & Antagonists
Product Name CCR1 CCR2 CCR3 CCR4 CCR5 CCR6 CCR7 CCR8 CCR9 Purity
Cenicriviroc  
CCR2, IC50: 5.9 nM
   
CCR5, IC50: 0.29 nM
        98.07%
Maraviroc        
MIP-1α-CCR5, IC50: 3.3 nM (in HEK-293 cell membrane)
MIP-1β-CCR5, IC50: 7.2 nM (in HEK-293 cell membrane)
RANTES-CCR5, IC50: 5.2 nM (in HEK-293 cell membrane)
        99.95%
RS 504393  
CCR2, IC50: 89 nM
              99.18%
INCB3344  
hCCR2, IC50: 5.1 nM
mCCR2, IC50: 9.5 nM
              99.73%
BMS CCR2 22  
CCR2, IC50: 5.1 nM
              >99.0%
CCR1 antagonist 9
CCR1, IC50: 6.8 nM (in calcium flux assay)
               
YM022
CCR1, Ki: 68 pM
CCR2, Ki: 63 nM
             
Cenicriviroc Mesylate  
CCR2, IC50: 5.9 nM
   
CCR5, IC50: 0.29 nM
        98.84%
BX471
MIP-1α-CCR1, Ki: 1 nM
RANTES-CCR1, Ki: 2.8 nM
MCP-3-CCR1, Ki: 5.5 nM
                99.78%
PF-4136309  
Human CCR2, IC50: 5.2 nM
Mouse CCR2, IC50: 13 nM
Rat CCR2, IC50: 17 nM
              99.59%
RS102895 hydrochloride
CCR1, IC50: 17800 nM
CCR2, IC50: 360 nM
              99.69%
TAK-779  
MCP-1-CCR2b, IC50: 27 nM (in CHO/CCR5 cells)
   
MIP-1β-CCR5, IC50: 1 nM (in CHO/CCR5 cells)
RANTES-CCR5, IC50: 1.4 nM (in CHO/CCR5 cells)
MIP-1α-CCR5, IC50: 1 nM (in CHO/CCR5 cells)
        99.73%
MK-0812 Succinate  
CCR2
              99.69%
AZD2098      
CCR4
          99.85%
Vercirnon                
CCR9, IC50: 10 nM
98.58%
BX471 hydrochloride
MIP-1α-CCR1, Ki: 1 nM
RANTES-CCR1, Ki: 2.8 nM
MCP-3-CCR1, Ki: 5.5 nM
                98.00%
BMS-813160  
CCR2
   
CCR5
        99.89%
INCB 3284  
MCP-1-hCCR2, IC50: 3.7 nM
              99.30%
GW 766994    
CCR3, pKi: 7.86
            99.53%
CCR2-RA-[R]  
CCR2, IC50: 103 nM (in U2OS-CCR2 cells)
              99.36%
TAK-220        
RANTES-CCR5, IC50: 3.5 nM (in CHO cells)
MIP-1α-CCR5, IC50: 1.4 nM (in CHO cells)
        99.95%
DAPTA        
gp120BaL/sCD4-CCR5, IC50: 55 pM (in Cf2Th/synR5 cells)
gp120CMCM235/sCD4-CCR5, IC50: 0.32 nM (in Cf2Th/synR5 cells)
        98.73%
ZK756326 dihydrochloride              
CCR8, IC50: 1.8 μM (in U87 cells)
  99.53%
GSK2239633A      
[125I]-TARC-CCR4, pIC50: 7.96
          99.77%
Vicriviroc maleate        
CCR5, Ki: 2.5 nM
        99.41%
AZ084              
CCR8, Ki: 0.9 nM
  99.36%
CCR6 inhibitor 1          
Moneky CCR6, IC50: 0.45 nM
Human CCR6, IC50: 6 nM
Human CCR7, IC50: 9400 nM
    99.82%
MK-0812  
CCR2
              99.75%
Teijin compound 1  
MCP-1-CCR2b, IC50: 180 nM
              99.89%
INCB 3284 dimesylate  
MCP-1-hCCR2, IC50: 3.7 nM
              >98.0%
PF-04634817  
CCR2
   
CCR5
        98.87%
CCR1 antagonist 8
CCR1, IC50: 1.8 nM (in Ca2+ flux assay)
               
J-113863
CCR1, IC50: 0.9 nM (Human CCR1)
CCR1, IC50: 5.8 nM (Mouse CCR1)
 
CCR3, IC50: 0.58 nM (Human CCR3)
CCR3, IC50: 460 nM (Mouse CCR3)
            >99.0%
CCR2 antagonist 1  
CCR2, Ki: 2.4 nM
             
CCR5 antagonist 1        
CCR5
       
CCR2 antagonist 3  
CCR2
             
Aplaviroc        
CCR5
       
C-021 dihydrochloride      
CCR4
          >99.0%
LMD-009              
CCR8, EC50: 11-87 nM
 
RS102895
CCR1, IC50: 17800 nM
CCR2, IC50: 360 nM
             
CCX354
CCR1
               
CCR3 antagonist 1    
CCR3